We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+13.11%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.02B
AUM Growth
+$31.2M
Cap. Flow
-$130M
Cap. Flow %
-6.43%
Top 10 Hldgs %
16.17%
Holding
2,969
New
1,707
Increased
193
Reduced
681
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 12.58%
3 Industrials 10.34%
4 Healthcare 9.4%
5 Consumer Discretionary 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNX icon
401
TD Synnex
SNX
$20.3B
$1.24M 0.06%
22,232
-504
-2% -$30K
CRM icon
402
Salesforce
CRM
$162B
$1.24M 0.06%
15,065
-12,004
-44% -$959K
TECD
403
DELISTED
Tech Data Corp
TECD
$1.24M 0.06%
13,218
-544
-4% -$48.1K
HRC
404
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.24M 0.06%
17,532
-421
-2% -$26.8K
JACK icon
405
Jack in the Box
JACK
$340M
$1.24M 0.06%
12,148
-419
-3% -$43.4K
NEU icon
406
NewMarket
NEU
$8.37B
$1.24M 0.06%
2,725
-60
-2% -$26.3K
SAIC icon
407
Saic
SAIC
$5.3B
$1.23M 0.06%
16,589
-573
-3% -$48.7K
PRXL
408
DELISTED
Parexel International Corp
PRXL
$1.23M 0.06%
19,557
-1,116
-5% -$73.8K
LHO
409
DELISTED
LaSalle Hotel Properties
LHO
$1.23M 0.06%
42,547
-1,168
-3% -$34.7K
GWR
410
DELISTED
Genesee & Wyoming Inc.
GWR
$1.23M 0.06%
18,070
-469
-3% -$33.9K
BIO icon
411
Bio-Rad Laboratories Class A
BIO
$9.48B
$1.22M 0.06%
6,129
-96
-2% -$18.5K
CAH icon
412
Cardinal Health
CAH
$55.5B
$1.21M 0.06%
14,887
+1,091
+8% +$85.9K
APD icon
413
Air Products & Chemicals
APD
$68.6B
$1.21M 0.06%
8,924
+328
+4% +$46.2K
KMT icon
414
Kennametal
KMT
$2.41B
$1.2M 0.06%
30,464
-675
-2% -$24.9K
LYV icon
415
Live Nation Entertainment
LYV
$43B
$1.19M 0.06%
39,216
-999
-2% -$28.6K
PTEN icon
416
Patterson-UTI
PTEN
$4.19B
$1.19M 0.06%
49,033
+4,068
+9% +$110K
FR icon
417
First Industrial Realty Trust
FR
$8.36B
$1.19M 0.06%
44,605
-1,081
-2% -$28.9K
TROW icon
418
T. Rowe Price
TROW
$24.3B
$1.19M 0.06%
17,434
+3,042
+21% +$216K
AAN.A
419
DELISTED
The Aaron's Company Inc Class A
AAN.A
$1.19M 0.06%
39,937
-16,000
-29% -$476K
AGCO icon
420
AGCO
AGCO
$7.06B
$1.18M 0.06%
19,673
-860
-4% -$52.9K
SLAB icon
421
Silicon Laboratories
SLAB
$7.2B
$1.18M 0.06%
16,101
SYY icon
422
Sysco
SYY
$40.1B
$1.18M 0.06%
22,796
+8,627
+61% +$457K
INTU icon
423
Intuit
INTU
$91.5B
$1.18M 0.06%
10,185
-268
-3% -$32.1K
TCO
424
DELISTED
Taubman Centers Inc.
TCO
$1.18M 0.06%
17,839
-361
-2% -$25K
AMD icon
425
Advanced Micro Devices
AMD
$767B
$1.18M 0.06%
80,825
-211,350
-72% -$2.68M

Similar funds

Ameritas Investment Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Ameritas Investment Partners held 2,969 positions worth $2.02B, up 1.6% from $1.99B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ameritas Investment Partners withdrew a net $130M in Q1 2017, closing 23 positions and reducing 681 holdings. Its most notable exit was Vanguard Total Bond Market, an estimated $34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Bioverativ Inc. Common Stock worth $2.4M.

  • Ameritas Investment Partners's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 44,128 shares worth $2.4M.
  • Ameritas Investment Partners added most to State Street Health Care Select Sector SPDR ETF in Q1 2017, an estimated $2.78M increase.
  • Ameritas Investment Partners's biggest Q1 2017 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $61.8M.
  • Ameritas Investment Partners fully exited Vanguard Total Bond Market in Q1 2017, selling an estimated $34M.
  • Ameritas Investment Partners's ten largest holdings make up 16% of its $2.02B portfolio in Q1 2017.
  • Ameritas Investment Partners opened 1,707 new positions and closed 23 in Q1 2017.
  • Ameritas Investment Partners's portfolio value rose 1.6% quarter-over-quarter to $2.02B.

Based on Ameritas Investment Partners's 13F filing for Q1 2017, filed 9 May 2017.